Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

USA - NASDAQ:SBC - US73245B1070 - Common Stock

4.15 USD
-0.04 (-1.07%)
Last: 10/20/2025, 4:30:02 PM
Fundamental Rating

5

Taking everything into account, SBC scores 5 out of 10 in our fundamental rating. SBC was compared to 101 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SBC was profitable.
SBC had a negative operating cash flow in the past year.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

SBC's Return On Assets of 10.57% is amongst the best of the industry. SBC outperforms 96.04% of its industry peers.
SBC has a Return On Equity of 13.63%. This is amongst the best in the industry. SBC outperforms 81.19% of its industry peers.
SBC's Return On Invested Capital of 22.45% is amongst the best of the industry. SBC outperforms 96.04% of its industry peers.
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROIC 22.45%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

SBC's Profit Margin of 17.71% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
SBC's Operating Margin of 38.45% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 76.97%, SBC belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
Industry RankSector Rank
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SBC is creating value.
Compared to 1 year ago, SBC has less shares outstanding
The debt/assets ratio for SBC has been reduced compared to a year ago.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SBC has an Altman-Z score of 6.69. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
SBC's Altman-Z score of 6.69 is amongst the best of the industry. SBC outperforms 89.11% of its industry peers.
SBC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
SBC has a better Debt to Equity ratio (0.03) than 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 6.69
ROIC/WACC2.66
WACC8.44%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.98 indicates that SBC has no problem at all paying its short term obligations.
The Current ratio of SBC (3.98) is better than 89.11% of its industry peers.
SBC has a Quick Ratio of 3.95. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.95, SBC belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.95
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.06% over the past year.
Looking at the last year, SBC shows a very strong growth in Revenue. The Revenue has grown by 74.40%.
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%

3.2 Future

SBC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.18% yearly.
SBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.13% yearly.
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SBC is valuated reasonably with a Price/Earnings ratio of 9.22.
Compared to the rest of the industry, the Price/Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 93.07% of the companies listed in the same industry.
SBC is valuated cheaply when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
SBC is valuated reasonably with a Price/Forward Earnings ratio of 8.56.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 95.05% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SBC to the average of the S&P500 Index (23.18), we can say SBC is valued rather cheaply.
Industry RankSector Rank
PE 9.22
Fwd PE 8.56
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaper than 97.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.89
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A cheap valuation may be justified as SBC's earnings are expected to decrease with -10.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (10/20/2025, 4:30:02 PM)

4.15

-0.04 (-1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners0.62%
Inst Owner ChangeN/A
Ins Owners89.24%
Ins Owner Change0%
Market Cap431.10M
Analysts80
Price Target7.91 (90.6%)
Short Float %1.19%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.84%
Min EPS beat(2)-85.33%
Max EPS beat(2)89.02%
EPS beat(4)2
Avg EPS beat(4)-21.1%
Min EPS beat(4)-98.74%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.51%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)28.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.54%
EPS NY rev (1m)-1.52%
EPS NY rev (3m)-27.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.82%
Valuation
Industry RankSector Rank
PE 9.22
Fwd PE 8.56
P/S 2.29
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 1.81
EV/EBITDA 3.89
EPS(TTM)0.45
EY10.84%
EPS(NY)0.48
Fwd EY11.68%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.81
BVpS2.35
TBVpS2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROCE 28.42%
ROIC 22.45%
ROICexc 56.12%
ROICexgc 60%
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.1
Cap/Depr 96.72%
Cap/Sales 1.65%
Interest Coverage 980.59
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.95
Altman-Z 6.69
F-Score5
WACC8.44%
ROIC/WACC2.66
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-567.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.7%
OCF growth 3YN/A
OCF growth 5YN/A